Skip to main content
Alkem Laboratories Limited logo

Alkem Laboratories Limited — Investor Relations & Filings

Ticker · ALKEM ISIN · INE540L01014 LEI · 335800GCAE5WIF4PSG69 BSE.NS Manufacturing
Filings indexed 1,788 across all filing types
Latest filing 2026-03-20 Regulatory Filings
Country IN India
Listing BSE.NS ALKEM

About Alkem Laboratories Limited

https://www.alkemlabs.com/

Alkem Laboratories Limited specializes in the development, manufacturing, and marketing of pharmaceutical and nutraceutical products. The company’s portfolio covers a wide range of therapeutic areas, including anti-infectives, gastrointestinal, pain management, and vitamins, minerals, and nutrients. It has also expanded into chronic therapeutic segments such as cardiology, diabetology, neurology, and dermatology. Alkem operates multiple manufacturing facilities and advanced research and development centers dedicated to formulation development and active pharmaceutical ingredients. The company provides branded generics, generic medications, and active pharmaceutical ingredients to various international markets. Its operations are supported by a robust supply chain and a focus on high-quality production standards to meet global regulatory requirements.

Recent filings

Filing Released Lang Actions
Please find attached herewith Intimation regarding receipt of EU GMP Certificate for the Company manufacturing facility located at Daman, India.
Regulatory Filings
2026-03-20 English
Press Release
Regulatory Filings Classification · 95% confidence The document is a short regulatory disclosure addressed to stock exchanges regarding the receipt of an EU GMP Certificate for a manufacturing facility. It references compliance with SEBI LODR Regulations and is an intimation of a regulatory event rather than a financial report or detailed filing. The document length is only 1575 characters, and it does not contain financial data, management discussion, or detailed report content. It is an announcement of a regulatory compliance event, fitting best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2026-03-20 English
Please find enclosed herewith the details of the Analyst / Investor meeting to be held on 26th March,2026.
Regulatory Filings
2026-03-20 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice addressed to stock exchanges about the schedule of an analyst/institutional investor meeting. It references SEBI regulations and provides details of the meeting date and participants. There is no financial data, report content, or detailed presentation included. The document is an announcement of a meeting schedule rather than a report or transcript. Given the nature and length (1226 characters), it fits best as a Regulatory Filing (RNS), which covers general regulatory announcements and miscellaneous filings that do not fit other categories.
2026-03-20 English
Updates
Capital/Financing Update Classification · 95% confidence The document is a disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to continuous disclosure obligations for listed companies. It announces the receipt of an allotment letter for land to set up a manufacturing facility and the board's approval of investment. This is an update on a capital investment and expansion plan, which fits the category of Capital/Financing Update (CAP). The document is short and does not contain financial statements or detailed financial data, so it is not an Annual Report or Interim Report. It is not a report publication announcement or regulatory filing in the fallback sense, but a specific capital investment disclosure under SEBI LODR. Therefore, the correct classification is CAP with high confidence.
2026-03-18 English
Please find attached herewith intimation regarding allotment of land for setting up of a greenfield formulations manufacturing facility of the Company in Ujjain, Madhya Pradesh.
Regulatory Filings
2026-03-18 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.